Development and Optimization of a Quantitative Assay for an Investigational Anti-Malarial Monoclonal Antibody Drug Candidate in Human Whole Blood Using Volumetric Absorptive Microsampling (VAMS)

Development and Optimization of a Quantitative Assay for an Investigational Anti-Malarial Monoclonal Antibody Drug Candidate in Human Whole Blood Using Volumetric Absorptive Microsampling (VAMS)

April 15, 2025 BioData Solutions

RSM01, a novel monoclonal antibody targeting RSV, promises to revolutionize prevention strategies, especially in low- and middle-income countries. Its innovative dried blood collection method simplifies clinical trials, making cutting-edge RSV prevention more accessible and impactful in remote, underdeveloped areas. Download the poster developed in collaboration with Gates Medical Research Institute and KCAS Bio to learn more.

App Notes

Cross-Validation of Statistical Workflow for Cut Point Calculation using Red Thread (Python) Vs R

September 17, 2024

Comparing Cut Points Between Statistical Software Stata and R Using Random Effects Model

September 17, 2024

Case Studies

Simplifying Bioanalytical Review Using Advanced Computational Techniques

September 17, 2024

Posters

Development and Optimization of a Quantitative Assay for an Investigational Anti-Malarial Monoclonal Antibody Drug Candidate in Human Whole Blood Using Volumetric Absorptive Microsampling (VAMS)

April 15, 2025

Assessing the Impact of Ultra-Low Cut Points in Immunogenicity Assays

December 2, 2024

Singlet Analysis Yields Equivalent Results as Duplicate Analysis in Preclinical Immunogenicity Assessment

September 17, 2024

Can Automation Improve Compliance, Consistency, & Efficiency for CGTP Data Analysis

September 17, 2024

White Papers

Artificial Intelligence increases efficiencies and reduces bias for bioanalytical pharmacokinetic studies and anti-drug antibody statistical determinations

September 17, 2024